Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality.

Rao S. et al, (2023), Eur Heart J

Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-Analysis.

Bidel Z. et al, (2023), Hypertension

Stratification of diabetes in the context of comorbidities, using representation learning and topological data analysis.

Wamil M. et al, (2023), Sci Rep, 13

Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk.

Rao S. et al, (2023), Heart

Systolic Blood Pressure and Cardiovascular Risk in Patients With Diabetes: A Prospective Cohort Study.

Rao S. et al, (2022), Hypertension

High-Frequency Rheological and Piezo-Voltage Waveform Characterization of Inkjet-Printed Polymer-Based Dopant-Source Inks.

Hussain Z. et al, (2022), Micromachines (Basel), 14

Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes - Authors' reply.

Nazarzadeh M. et al, (2022), Lancet Diabetes Endocrinol, 10, 841 - 842

Blood pressure and risk of venous thromboembolism: a cohort analysis of 5.5 million UK adults and Mendelian randomization studies.

Nazarzadeh M. et al, (2022), Cardiovasc Res

Correction: Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions.

Canoy D. et al, (2022), Osteoporos Int

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.

Nazarzadeh M. et al, (2022), Lancet Diabetes Endocrinol

How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients With and Without Previous Cardiovascular Disease?

Canoy D. et al, (2022), Current Cardiology Reports, 24, 851 - 860

Investigating the association of environmental exposures and all-cause mortality in the UK Biobank using sparse principal component analysis.

Mamouei M. et al, (2022), Sci Rep, 12

ABCG2, SCN1A and CYP3A5 genes polymorphism and drug-resistant epilepsy in children: A case-control study

Mousavi SF. et al, (2022), Seizure, 97, 58 - 62

The Blood Pressure Lowering Treatment Trialists' Collaboration: methodological clarifications of recent reports.

Nazarzadeh M. et al, (2022), J Hypertens

Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials

Canoy D. et al, (2022), Heart

Blood pressure-lowering for prevention of major cardiovascular diseases in persons with and without type 2 diabetes

Nazarzadeh M. and Rahimi K., (2022), DIABETES RESEARCH AND CLINICAL PRACTICE, 186

Inkjet- and FlexTrail-printing of Silicon Polymer-based Inks for Local Passivating Contacts

Zohreh K. et al, (2022), 11TH INTERNATIONAL CONFERENCE ON CRYSTALLINE SILICON PHOTOVOLTAICS (SILICONPV 2021), 2487

The association of dietary insulin load and index with the risk of cancer and cancer mortality: a systematic review and meta-analysis

Teymoori F. et al, (2022), Journal of Diabetes and Metabolic Disorders

Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.

Nazarzadeh M. et al, (2021), Lancet, 398, 1803 - 1810

Blood pressure treatment: how low should you go? - Authors' reply.

Rahimi K. et al, (2021), Lancet, 398, 1684 - 1685

Load More

1
2
3
4
5
6

Include forthcoming?